Immediate Clinical Assessment and Repeat Laboratory Testing Required
This patient requires urgent clinical evaluation and repeat complete blood count with differential within 24-48 hours to determine the cause of her marked leukocytosis (WBC 22.1 with ANC 17.0) and guide further management. The constellation of findings—leukocytosis, thrombocytosis, hypokalemia, and low bicarbonate—suggests an acute inflammatory or infectious process that must be identified and treated promptly 1, 2.
Priority Actions
1. Assess for Infection/Inflammatory Process
The marked neutrophilic leukocytosis (ANC 17.0 × 10⁹/L) with thrombocytosis is most consistent with a reactive process rather than primary hematologic malignancy 1, 2. Specifically evaluate for:
- Respiratory symptoms: cough, dyspnea, chest pain (obtain chest X-ray if present)
- Abdominal symptoms: severe pain, diarrhea, vomiting (the low bicarbonate and hypokalemia suggest possible GI losses)
- Urinary symptoms: dysuria, frequency, flank pain (though the yeast on urine culture at 10,000-25,000 CFU/mL is likely colonization, not infection)
- Skin/soft tissue: erythema, warmth, swelling, wounds
- Recent medication changes: particularly corticosteroids, which can cause marked leukocytosis
Critical point: Isolated infection-related hyperleukocytosis (WBC >100 × 10⁹/L) is exceedingly rare in non-hematologic conditions 3, but leukocytosis in the 20s range is commonly seen with bacterial infections 1.
2. Repeat Laboratory Testing Within 24-48 Hours
- CBC with differential and peripheral smear: Confirm the leukocytosis, assess for left shift, toxic granulation, or abnormal cells that would suggest malignancy 1, 2
- Basic metabolic panel: Reassess potassium and bicarbonate
- C-reactive protein: Elevated CRP supports acute inflammatory/infectious process 4
3. Address Electrolyte Abnormalities
- Hypokalemia (K 3.4 mmol/L): Increase dietary potassium intake and consider oral potassium supplementation (20-40 mEq daily) if dietary measures insufficient
- Low bicarbonate (CO₂ 19 mmol/L): Assess for metabolic acidosis with arterial blood gas if clinically indicated; likely related to GI losses if diarrhea present
4. Manage the Yeast in Urine
The 10,000-25,000 CFU/mL yeast with normal urinalysis represents colonization, not infection, in an asymptomatic patient. Do not treat with antifungals unless she has urinary symptoms, risk factors for invasive candidiasis (immunosuppression, recent broad-spectrum antibiotics, indwelling catheter), or signs of systemic infection 5. Assess for vulvovaginal candidiasis symptoms and treat topically if present.
Hematologic Malignancy Evaluation
While the leukocytosis pattern (neutrophilic with normal lymphocyte count of 3.7 × 10⁹/L) favors a reactive process, peripheral smear review is essential to exclude:
- Chronic myeloid leukemia: Would show basophilia, left shift with myelocytes/metamyelocytes, and requires BCR-ABL testing 6
- Myeloproliferative neoplasms (polycythemia vera, essential thrombocythemia): The thrombocytosis (572 × 10⁹/L) combined with leukocytosis could suggest ET, but her hemoglobin is normal 7, 8, 9, 10
- Acute leukemia: Would show blasts on smear 5, 11, 12
If the peripheral smear shows:
- Blasts or immature cells → immediate hematology referral and bone marrow biopsy
- Left shift with basophilia → BCR-ABL testing for CML
- Normal maturation with toxic changes → supports reactive process
Management of Chronic Conditions
Dyslipidemia
Continue atorvastatin 20 mg daily. The LDL of 143 mg/dL remains above goal; confirm medication adherence before dose escalation. Consider increasing to 40 mg daily if adherent.
Vitamin D Insufficiency
Continue vitamin D3 2,000 IU daily. Level of 24.4 ng/mL shows improvement but remains suboptimal (goal >30 ng/mL).
Glycemic Control
A1c of 5.3% on tirzepatide 5 mg is excellent. Continue current regimen.
Elevated Alkaline Phosphatase
The isolated elevation (159 U/L) with normal ALT/AST/bilirubin requires repeat hepatic function panel after acute illness resolves. Consider GGT to determine if hepatic or bone source. If persistent, obtain right upper quadrant ultrasound.
Follow-Up Timeline
- 24-48 hours: Repeat CBC with differential, BMP, CRP
- 1 week: Clinical reassessment if acute process identified and treated
- 2-4 weeks: Repeat hepatic function panel, CBC to confirm resolution of leukocytosis and thrombocytosis
- If leukocytosis persists without identified cause: Hematology referral for bone marrow evaluation and JAK2 mutation testing 7, 8, 9
The key pitfall to avoid is assuming this is a primary hematologic malignancy without first excluding reactive causes, which are far more common in this clinical scenario 1, 2, 3.